Yubo Wang
- Molecular Biology
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Physiology top 10%
- Topics
- Lung Cancer Treatments and Mutations (27 papers)PI3K/AKT/mTOR signaling in cancer (15 papers)Metabolism, Diabetes, and Cancer (9 papers)
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Yubo Wang
66 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 105
- Molecular Biology 690
- Oncology 521
- Pulmonary and Respiratory Medicine 484
- Cancer Research 230
- Physiology 195
Countries citing papers authored by Yubo Wang
This map shows the geographic impact of Yubo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yubo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yubo Wang more than expected).
Fields of papers citing papers by Yubo Wang
This network shows the impact of papers produced by Yubo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yubo Wang. The network helps show where Yubo Wang may publish in the future.
Co-authorship network of co-authors of Yubo Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Yubo Wang. A scholar is included among the top collaborators of Yubo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yubo Wang. Yubo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 13 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 6 | |
| 9 | 26 | |
| 10 | 5 | |
| 11 | 9 | |
| 12 | 20 | |
| 13 | 12 | |
| 14 | 26 | |
| 15 | 68 | |
| 16 | 26 | |
| 17 | 23 | |
| 18 | 14 | |
| 19 | 11 | |
| 20 | 204 |
About Yubo Wang
Yubo Wang is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology, having authored 69 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (27 papers), PI3K/AKT/mTOR signaling in cancer (15 papers) and Metabolism, Diabetes, and Cancer (9 papers). The work is most often cited by research in Oncology (521 citations), Cancer Research (230 citations) and Pulmonary and Respiratory Medicine (484 citations). Yubo Wang has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Yong He, Li Li, Rui Han, Caiyu Lin, Hengyi Chen, Conghua Lu, Bailong Xiao, Kunlin Li, Fenfen Sun and Hualiang Xiao. Their work appears in journals such as PLoS ONE, The Journal of Physiology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.